Skip to main content

Former Cy Young Winner Working His Way Back From Major Injury For San Francisco Giants

The San Francisco Giants have had an eventful offseason and one of their biggest additions, pitcher Robbie Ray, is working his way back from Tommy John surgery.

New San Francisco Giants' pitcher Robbie Ray is working his way back from Tommy John surgery and appears to be on track to debut with his new team by midsummer.

Per Alex Pavlovic on social media:

Some Day 1 updates: Slater (elbow) has no hitting restrictions, is finishing throwing program ... Ray is throwing 3 times a week, is on schedule ... Reggie Crawford has a lat strain and won't throw for 3-4 weeks ... Kai-Wei Teng will miss at least 2-3 weeks with oblique strain.

The Giants acquired Ray in an offseason deal with the Seattle Mariners. They shipped Anthony DeSclafani and Mitch Haniger to Seattle in the move.

Ray signed with the Mariners before the 2022 season, helping the team get to the playoffs for the first time since 2001. In that season, he went 12-12 with a 3.71 ERA over 32 starts. He made just one start in 2023, suffering the elbow injury in that first start.

Lifetime, Ray is 74-71 in his career, which spans 10 years with the Tigers, Diamondbacks, Blue Jays and Mariners.

He won the Cy Young with Toronto in 2021 and is a one-time All-Star.

If he is able to re-join the Giants at midseason, he'd join a rotation that figures to be anchored by Logan Webb and Jordan Hicks and will also feature Alex Cobb and youngster Kyle Harrison.

San Francisco finished fourth in the National League West a season ago and failed to make the playoffs. In an effort to get to the playoffs this year, they've acquired Ray and signed outfielders Jorge Soler and Jung Ho Lee.

Follow Fastball on FanNation on social media

Continue to follow our Fastball on FanNation coverage on social media by LIKING us on Facebook and by following us on Twitter @FastballFN.

Check out more San Francisco Giants coverage at Sports Illustrated and FanNation's Giants Baseball Insider.